Retraction: Serum Calprotectin Correlates With Risk And Disease Severity In Psoriasis Patients And The Decrease Of Calprotectin Predicts Better Response To Tumor Necrosis Factor Inhibitors (Retraction Of Vol 22, Pg 4299, 2018)

The article “Serum calprotectin correlates with risk and disease severity in psoriasis patients and the decrease of calprotectin predicts better response to tumor necrosis factor inhibitors, by M. Qian, N.-J. Song, published in Eur Rev Med Pharmacol Sci 2018; 22 (13): 4299-4309–DOI: 10.26355/eurrev_201807_15426–PMID: 30024620” has been withdrawn from the authors since the conclusions of the paper had some shortcomings and the authors decided to improve them further. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/15426